P2shortA

General Information


DRACP ID  DRACP05919

Peptide Name   P2shortA

Sequence  ALPISTVRⓍVALⓍRRL

Sequence Length  16

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Stapled Peptides Induce apoptosis Induce cell cycle arrest MDM6/MDMX Inhibitor



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma 50% Killing=10 μM Crystal violet dye 24, 48 or 72 h 1
PC-9 Lung adenocarcinoma Carcinoma 80% Killing=10 μM Crystal violet dye 24, 48 or 72 h 1
NCI-H358 Minimally invasive lung adenocarcinoma Carcinoma 98% Killing=10 μM Crystal violet dye 24, 48 or 72 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  74

Linear/Cyclic  Cyclic (Stapled)

Disulfide/Other Bond  Stapled: Ⓧ(9) and Ⓧ (13) are cross-linked by hydrocarbon stapling

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  Ⓧ=(S)-pentenylalanine

Chiral  L



Physicochemical Information


Formula  C70H125N23O15

Absent amino acids  CDEFGHKMNQWY

Common amino acids  LR

Mass  179664

Pl  12.8

Basic residues  3

Acidic residues  0

Hydrophobic residues  8

Net charge  3

Boman Index  -1935

Hydrophobicity  70.63

Aliphatic Index  146.25

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32104498

Title  Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growth

Doi 0.7150/thno.40971

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.